Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, TRI, FVT

Vice President of Avirmax Inc. will Chair Sessions at the 27th ASGCT 2024 Annual Conference in Baltimore


HAYWARD, Calif., March 29, 2024 /PRNewswire/ -- Li Ou, Ph.D., Vice President of Research at Avirmax Inc., will chair two scientific sessions at the upcoming American Society of Gene and Cell Therapy (ASGCT) annual meeting in Baltimore between May 7th and 11th, 2024. ASGCT is the largest international society dedicated to understanding, development, and application of gene and cell therapy.

Dr. Li Ou of Avrimax pushes for fundamental scientific understanding of AAV vectors with session chairing at ASGCT'24

These two sessions that Dr. Ou chairs will be:

Session Title: A3 - AAV Vectors - Capsid Engineering Session 1
Date and Time: Wednesday, May 8, 2024, 3:45 PM

Session Title: 2nd Annual 5-Minute Thesis Challenge
Date and Time: Friday, May 10, 2024, 8:00 AM

Dr. Li Ou is a current committee member of ASGCT and a well-established investigator in preclinical research in AAV gene therapy and gene editing. Dr. Ou joined Avirmax in July 2023 and has since been leading in expanding the Company's research programs in capsid engineering and in vivo programs. An avid advocator of unlocking the hidden potential of AAV, Dr. Ou is dedicated to the groundwork of translational development while spearheading institutional collaboration. Before joining Avirmax, Dr. Ou was an Assistant Professor at the University of Minnesota, where he spearheaded research on gene therapy for lysosomal diseases, resulting in two IND approvals from the FDA. On Feb 16th, he moderated the ASGCT Professional Development Café online webinar, featuring a talk on Utilizing AI in Gene & Cell Manufacturing.

In addition to the scientific sessions, Avirmax will exhibit in booth #818 showcasing the latest AAV platform technologies.

About Avirmax Inc.
Avirmax Inc. is a San Francisco-based company specializing in developing rAAV-mediated therapeutics for ocular diseases using its AAV proprietary capsid engineering technologies and Sf9-based rAAV manufacturing platform. Since its inception, Avirmax has been dedicated to developing safe, effective, affordable, and accessible AAV gene therapy products for the unmet needs of patients. Visit us at avirmax.com for more information.    

Contact

Please contact
June Song, Associate Director of Operations
Email: [email protected]
Tel: +1-510-641-0201

Address
25503 Whitesell Street
Hayward, CA 94545
USA

SOURCE Avirmax


These press releases may also interest you

at 08:40
Longevity Biotech, Timeline, Leads the Way in Healthy Aging Research with Groundbreaking Clinical Studies
Regulatory News: Timeline®, a pioneering Swiss consumer biotech company at the forefront of longevity research, is proud to announce the successful completion of its landmark immune aging clinical study, MitoImmune, using Mitopure (proprietary...

at 08:36
Staples Canada and MAP launch the largest Even the Odds fundraising campaign to date with 'Close the Gap'
Staples Canada is amplifying its support for MAP, Canada's largest health equity research centre, to 'Close the Gap' on inequity in Canada. This campaign marks the fourth year of its Even The Odds partnership with the world-renowned organization....

at 08:35
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones 
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, provides a...

at 08:34
GIST-MIT CSAIL Researchers Develop A Biomechanical Dataset for Badminton Performance Analysis
In sports training, practice is the key, but being able to emulate the techniques of professional athletes can take a player's performance to the next level. AI-based personalized sports coaching assistants can make this a reality by utilizing...

at 08:31
Renowned Life Coach and Energy Healer, Daniel Rosenstein, Launches Groundbreaking Heartbreak Healing Program
Daniel Rosenstein, a leading figure in the fields of life coaching and energy healing, is proud to announce the launch of his latest initiative: the Heartbreak Healing Program. Designed to help individuals overcome the pain and emotional baggage of...

at 08:30
symplr is Recognized as a 2024 U.S. Best Managed Company
symplr®, a leading provider of enterprise healthcare operations software, today announced it has been selected as a 2024 U.S. Best Managed company. Now in its fifth year, the award, sponsored by Deloitte and The Wall Street Journal, recognizes the...

More news about Health...


News published on and distributed by: